These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 6897520

  • 1. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM, Casassus P, Coscas Y, Darmont J, Goubeau C, Katz M, Jacquillat C, Tricot G, Weil M.
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract] [Full Text] [Related]

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
    Bonadonna G.
    Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
    [Abstract] [Full Text] [Related]

  • 4. Pediatric Hodgkin's disease.
    Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM.
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [Abstract] [Full Text] [Related]

  • 5. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E, Kende G, Many A, Ramot B.
    Harefuah; 1974 Apr 01; 86(7):348-51. PubMed ID: 4846045
    [No Abstract] [Full Text] [Related]

  • 6. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ, Wrigley PF, Hunter A, Crowther D, Malpas JS, Peckham MJ, Smithers DW, Fairley GH.
    Natl Cancer Inst Monogr; 1973 May 01; 36():395-402. PubMed ID: 4744597
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M, Teillet F, Weisgerber C, Dana M, Jacquillat C, Bernard J.
    Rev Prat; 1974 Oct 11; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB, Barista I, Hess MA, Cabanillas F, Cox JD.
    Cancer; 2002 Dec 15; 95(12):2534-8. PubMed ID: 12467067
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B, Alaoui Y, Kuentz M, Baillet F, Maylin C, Vernant JP, Reyes F, Rochant H, Pierquin B, Dreyfus B.
    Ann Med Interne (Paris); 1980 Dec 15; 131(4):239-43. PubMed ID: 7425449
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Combined chemotherapy in disseminated Hodgkin's disease].
    Armata J.
    Pol Tyg Lek; 1972 Jul 12; 27(24):927-9. PubMed ID: 4557231
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
    Hakvoort-Cammel FG, Buitendijk S, van den Heuvel-Eibrink M, Hählen K.
    Pediatr Blood Cancer; 2004 Jul 12; 43(1):8-16. PubMed ID: 15170884
    [Abstract] [Full Text] [Related]

  • 17. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug 12; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 18. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG, Pieresca C, Cavanna L, Corbella F, Vallisa D, Federico M, Formisano R, Carotenuto M, Merli F, Callea V, Angrilli F, Silingardi V.
    Haematologica; 1996 Aug 12; 81(6):503-12. PubMed ID: 9009437
    [Abstract] [Full Text] [Related]

  • 19. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT.
    Natl Cancer Inst Monogr; 1973 May 12; 36():373-9. PubMed ID: 4744596
    [No Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S, Morgenfeld M, Somoza N, Magnasco J, Sackmann Muriel F, Cavagnaro F, Suárez A, Barros CA, Saslavsky J, Garay G, Palau M, Besuschio SC.
    Medicina (B Aires); 1981 May 12; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.